| Ytd | 20.50% | |
| 1y | 78.41% |
| Open | 29.91 | Prev Close | 28.85 | Low | 27.59 | High | 29.91 | Mkt Cap | 49.57M |
| Vol | 94.47K | Avg Vol | 89.40K | EPS | -0.62 | P/E | N/A | Forward P/E | 13.34 |
| Beta | 1.42 | Short Ratio | 0.59 | Inst. Own | 8.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 24.59 | 200-d Avg | 24.94 | 1yr Est | 19.00 |
PRPO News
Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more co
PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record prod
Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.12) per share. This is a 340 percent decreas
Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cas
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) passed below its 200-day moving average during tradi
NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock l
NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics compa
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio,
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and hig
Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decre
Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive s
NEW HAVEN, Conn. , May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
AI demand and pipeline growth headline top Zacks stock reports on NVIDIA, Mastercard and AbbVie.
NEW HAVEN, Conn. , May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript
Precipio (NASDAQ: PRPO - Get Free Report) and Healthcare Triangle (NASDAQ: HCTI - Get Free Report) a
NEW HAVEN, Conn., March 12, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio,
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces some preliminary (unaud
Precipio (NASDAQ:PRPO) reported quarterly earnings of $0.05 per share. This is a 106.02 percent incr
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has entered into an agreement with
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces the launch of a new vers
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that its unaudited non-
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that for Q2-2024, its u
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into a di
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces that continued revenue g
During the session on Thursday, 461 stocks hit new 52-week lows.
Monday's session saw 175 companies set new 52-week lows.
Friday's session saw 59 companies set new 52-week lows.
On Friday, 54 companies hit new 52-week lows.
Friday's session saw 32 companies set new 52-week lows.
On Tuesday, 32 companies reached new 52-week lows.
During Thursday, 35 stocks hit new 52-week lows.
On Friday, 127 companies set new 52-week lows.
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after droppi
On Friday, 1043 companies hit new 52-week lows.